Faculty Publications

A finalized phase II report of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM).

Simon GR, Janne PA, Langer C, Clarie V, Dowlati A, Gadgeel SM, Kelly K, Ye Z, Obasaju CK, Hood KE, Kindler HL

A finalized phase II report of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM).

J Clin Oncol. 2006 Jun;24(18):91S-91S.

Abstract

Last updated on Saturday, November 21, 2009